116 related articles for article (PubMed ID: 36004447)
1. Therapeutic intervention of glioma with the novel antineoplastic agent T11TS: the story so far.
Chaudhuri S; Acharya S; Chaudhuri S
Immunotherapy; 2022 Oct; 14(15):1263-1277. PubMed ID: 36004447
[TBL] [Abstract][Full Text] [Related]
2. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
[TBL] [Abstract][Full Text] [Related]
3. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.
Bhattacharya D; Singh MK; Chaudhuri S; Acharya S; Basu AK; Chaudhuri S
J Neurooncol; 2013 May; 113(1):13-25. PubMed ID: 23471571
[TBL] [Abstract][Full Text] [Related]
4. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
5. Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells.
Acharya S; Chatterjee S; Chaudhuri S; Singh MK; Bhattacharya D; Bhattacharjee M; Ghosh A; Chaudhuri S
Cancer Invest; 2021 Nov; 39(10):854-870. PubMed ID: 34569407
[TBL] [Abstract][Full Text] [Related]
6. T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.
Singh MK; Chaudhuri S; Bhattacharya D; Kumar P; Datta A; Chaudhuri S
Int Immunopharmacol; 2015 Feb; 24(2):198-207. PubMed ID: 25528475
[TBL] [Abstract][Full Text] [Related]
7. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.
Bhattacharya D; Singh MK; Chaudhuri S; Datta A; Chaudhuri S
J Cell Physiol; 2017 Mar; 232(3):526-539. PubMed ID: 27255231
[TBL] [Abstract][Full Text] [Related]
8. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
9. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
[TBL] [Abstract][Full Text] [Related]
10. Induction of G1 arrest in glioma cells by T11TS is associated with upregulation of Cip1/Kip1 and concurrent downregulation of cyclin D (1 and 3).
Acharya S; Chatterjee S; Kumar P; Bhattacharjee M; Chaudhuri S; Chaudhuri S
Anticancer Drugs; 2010 Jan; 21(1):53-64. PubMed ID: 19829098
[TBL] [Abstract][Full Text] [Related]
11. Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy.
Chaudhuri S; Bhattacharya D; Singh MK; Moitra S; Ronsard L; Ghosh TK; Chaudhuri S
Mol Immunol; 2015 Oct; 67(2 Pt B):256-64. PubMed ID: 26105805
[TBL] [Abstract][Full Text] [Related]
12. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.
Bhattacharjee M; Acharya S; Ghosh A; Sarkar P; Chatterjee S; Kumar P; Chaudhuri S
Int Immunol; 2008 Dec; 20(12):1489-505. PubMed ID: 18931364
[TBL] [Abstract][Full Text] [Related]
13. Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.
Kumar P; Chatterjee S; Acharya S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2013; 284(1-2):172-81. PubMed ID: 23994239
[TBL] [Abstract][Full Text] [Related]
14. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
[TBL] [Abstract][Full Text] [Related]
15. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells.
Mukherjee J; Ghosh A; Ghosh A; Chaudhuri S
Cancer Biol Ther; 2006 Feb; 5(2):156-64. PubMed ID: 16357521
[TBL] [Abstract][Full Text] [Related]
16. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions.
Singh MK; Bhattacharya D; Chaudhuri S; Acharya S; Kumar P; Santra P; Basu AK; Chaudhuri S
Tumour Biol; 2014 Mar; 35(3):2231-46. PubMed ID: 24242015
[TBL] [Abstract][Full Text] [Related]
17. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment.
Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S
Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495
[TBL] [Abstract][Full Text] [Related]
18. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
[TBL] [Abstract][Full Text] [Related]
19. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
20. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3.
Begum Z; Ghosh A; Sarkar S; Mukherjee J; Mazumdar M; Sarkar P; Chaudhuri S
Glycoconj J; 2004; 20(9):515-23. PubMed ID: 15454689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
